Skip to main content
Earnings Labs
Alnylam Pharmaceuticals, Inc. logo

Alnylam Pharmaceuticals, Inc. (ALNY)

NASDAQ·Healthcare·Biotechnology

$278.20

-1.36%

Mkt Cap $37.76B

Analyst Ratings

Buy

18

Hold

4

Sell

0

Price Target (67 analysts)

$460.50

Range $351.00$549.00

Implied Upside

+65.5%

Consensus $460.50 vs current $278.20